Biologic Therapies Online Series

Webcasts

Rheumatology and Infectious Disease

What’s New in SpA and RA

Cytokine Storm in the COVID Era

Immune-based Inflammatory Diseases Through the Lens of COVID-19

Specific Questions in Vasculitis Treatment

Rheumatology – Dermatology

Rheumatology – Ophthalmology

Rheumatology – Pulmonology

Rheumatology – Oncology

Rheumatology – Neurology

Rheumatology – Infectious Disease

Series Learning Objectives

• Discuss factors that influence the selection of treatments for vasculitis disorders.

• Outline how data on the efficacy and side effect profiles for different vasculitis therapies impact decisions for choice of agent, dose, and duration.

• Describe the evidence base supporting diverse therapies for ANCA-associated vasculitis, including rituximab, conventional immunosuppressive agents, glucocorticoids, and plasma exchange.

• Summarize evidence on COVID-19: vaccinations, cytokine storm, and effects on patients with autoimmune disease, and describe the implications for clinical practice.

• Define the current status of targeted therapies, especially anti-TNF, anti-IL17, IL-23, and JAK inhibitors, in rheumatoid arthritis and spondyloarthritis.

• Assess the clinical impact of recent evidence on treatment of patients with immune-mediated inflammatory diseases including vaccines, COVID-19, and targeted therapies.

• Describe strategies for preventing infectious complications associated with immune-mediated inflammatory diseases.

Target Audience

The online series is designed for rheumatologists, dermatologists, infectious disease physicians, allergists, clinical immunologists, as well as specialists in integrative medicine, preventive medicine, wellness, primary care, and other health care professionals caring for patients with vasculitis and immune-mediated inflammatory diseases.

Activity Directors

Cassandra Calabrese, DO
Department of Rheumatic and Immunologic Diseases
Orthopaedic and Rheumatologic Institute
Cleveland Clinic
Cleveland, OH

Leonard H. Calabrese, DO
Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
R.J. Fasenmyer Chair of Clinical Immunology
Department of Rheumatic and Immunologic Diseases
Orthopaedic and Rheumatologic Institute
Cleveland Clinic
Cleveland, OH

M. Elaine Husni, MD, MPH
Director, Arthritis and Musculoskeletal Treatment Center
Vice Chair, Department of Rheumatic and Immunologic Diseases
Orthopaedic and Rheumatologic Institute
Cleveland Clinic
Cleveland, OH

Carol Langford, MD, MHS, FACP
Director, Center for Vasculitis Care and Research
Department of Rheumatic and Immunologic Diseases
Orthopaedic and Rheumatologic Institute
Cleveland Clinic
Cleveland, OH